龍虎榜丨鴻博股份連續第二日升停 1家機構高位接力淨買入2610.38萬元
格隆匯5月26日丨鴻博股份連續第二日升停,今年迄今累計升幅達到290%,全天成交額23.22億元,換手率18.41%。龍虎榜數據顯示,今日買四為機構席位,該席位淨買入2610.38萬元。榜單上出現了3家實力營業部的身影,分別位列買五、賣一、賣四,合計買入2810.48萬元,賣出1.35億元,淨額為-1.07億元。買五為國泰君安證券上海江蘇路營業部,該席位買入2586.64萬元,賣出11.79萬元,淨買額為2574.85萬元。賣一為東方證券上海浦東新區源深路證券營業部,該席位淨賣出1億元。賣四為東亞前海證券上海分公司,該席位淨賣出3207.46萬元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.